UBS Group’s Kodiak Sciences KOD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.41M | Buy |
190,115
+36,949
| +24% | +$1.44M | ﹤0.01% | 3779 |
|
|
2026
Q1 | $5.84M | Sell |
153,166
-15,396
| -9% | -$398K | ﹤0.01% | 3907 |
|
|
2025
Q4 | $4.71M | Buy |
168,562
+111,853
| +197% | +$2.29M | ﹤0.01% | 4089 |
|
|
2025
Q3 | $928K | Sell |
56,709
-2,394
| -4% | -$20.6K | ﹤0.01% | 5638 |
|
|
2025
Q2 | $220K | Buy |
59,103
+1,342
| +2% | +$4.75K | ﹤0.01% | 6654 |
|
|
2025
Q1 | $162K | Sell |
57,761
-109,800
| -66% | -$597K | ﹤0.01% | 6692 |
|
|
2024
Q4 | $1.67M | Buy |
167,561
+151,830
| +965% | +$873K | ﹤0.01% | 4906 |
|
|
2024
Q3 | $41.1K | Buy |
15,731
+2,022
| +15% | +$5.38K | ﹤0.01% | 6942 |
|
|
2024
Q2 | $32.2K | Sell |
13,709
-24,990
| -65% | -$84.7K | ﹤0.01% | 7015 |
|
|
2024
Q1 | $204K | Sell |
38,699
-4,423
| -10% | -$21.7K | ﹤0.01% | 5842 |
|
|
2023
Q4 | $131K | Buy |
43,122
+19,733
| +84% | +$43.9K | ﹤0.01% | 6033 |
|
|
2023
Q3 | $42.1K | Buy |
23,389
+2,049
| +10% | +$7.23K | ﹤0.01% | 6406 |
|
|
2023
Q2 | $147K | Buy |
21,340
+8,854
| +71% | +$54.1K | ﹤0.01% | 5703 |
|
|
2023
Q1 | $77.4K | Buy |
12,486
+104
| +0.8% | +$728 | ﹤0.01% | 6122 |
|
|
2022
Q4 | $88.7K | Buy |
12,382
+5,807
| +88% | +$41.7K | ﹤0.01% | 6218 |
|
|
2022
Q3 | $51K | Buy |
6,575
+6,550
| +26,200% | +$63.6K | ﹤0.01% | 6337 |
|
|
2022
Q2 | $0 | Hold |
25
| – | – | ﹤0.01% | 10641 |
|
|
2022
Q1 | $0 | Sell |
25
-2,049
| -99% | -$80K | ﹤0.01% | 10592 |
|
|
2021
Q4 | $176K | Sell |
2,074
-24,823
| -92% | -$2.53M | ﹤0.01% | 5811 |
|
|
2021
Q3 | $2.58M | Buy |
26,897
+26,766
| +20,432% | +$2.47M | ﹤0.01% | 3354 |
|
|
2021
Q2 | $12K | Sell |
131
-19,219
| -99% | -$1.84M | ﹤0.01% | 7885 |
|
|
2021
Q1 | $2.19M | Buy |
19,350
+10,291
| +114% | +$1.41M | ﹤0.01% | 3474 |
|
|
2020
Q4 | $1.33M | Buy |
9,059
+8,355
| +1,187% | +$931K | ﹤0.01% | 3777 |
|
|
2020
Q3 | $42K | Buy |
704
+534
| +314% | +$26.8K | ﹤0.01% | 5774 |
|
|
2020
Q2 | $9K | Sell |
170
-8,368
| -98% | -$472K | ﹤0.01% | 7082 |
|
|
2020
Q1 | $407K | Sell |
8,538
-11,372
| -57% | -$682K | ﹤0.01% | 4146 |
|
|
2019
Q4 | $1.43M | Sell |
19,910
-1,467
| -7% | -$53.4K | ﹤0.01% | 3872 |
|
|
2019
Q3 | $307K | Buy |
21,377
+15,296
| +252% | +$200K | ﹤0.01% | 4927 |
|
|
2019
Q2 | $71K | Buy |
+6,081
| New | +$54.1K | ﹤0.01% | 5630 |
|
|
2019
Q1 | – | Sell |
-3,506
| Closed | -$25K | – | 7946 |
|
|
2018
Q4 | $25K | Buy |
+3,506
| New | +$31K | ﹤0.01% | 6613 |
|
Other funds holding KOD
BBA
B
JT
RI
BCM
UBS Group's KOD Position: Q2 2026 in Review
UBS Group increased its Kodiak Sciences (KOD) stake by 24% in Q2 2026, buying an estimated $1.44M and bringing the position to 190,115 shares worth $7.41M. The position accounts for ﹤0.01% of the portfolio, ranked #3779.
UBS Group first reported a position in KOD in Q4 2018 and has held it in 30 quarters since. 200 funds tracked by Wall St. Rank hold KOD as of Q2 2026.
- UBS Group held 190,115 shares of Kodiak Sciences worth $7.41M as of Q2 2026.
- UBS Group bought 36,949 Kodiak Sciences shares in Q2 2026, an estimated $1.44M.
- Kodiak Sciences made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3779 holding.
- UBS Group first reported a position in Kodiak Sciences in Q4 2018 and has held it in 30 quarters since.
- 200 funds tracked by Wall St. Rank held Kodiak Sciences as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.